Nexia Biotechnologies Inc Company Profile
Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and BioSteelR.On March 7, 2005, Nexia's, shareholders approved the sale of substantially all its operations and assets related to ProtexiaR to PharmAthene (www.pharmathene.com), a privately held biotechnology company focused on the development of biodefense therapeutics, based in Annapolis, Maryland, USA.
P.O. BOX 187Branch Jean-Talon
Nexia Biotechnologies (complex recombinant proteins) will collaborate with the Institute of Plant Genetics & Crop Plant Research (IPG) in developing a method for manufacturing spider silk proteins in ...
ExpreS2ion Biotechnologies is a world leading contract research organization (CRO) for the production in Drosophila Schneider-2 (S2) cells using its proprietary and complete S2 recombinant protein tec...
Adaptive Biotechnologies said it secured $94 million in private equity funding and used the money to acquire Sequenta, an imm -More-
Minerva Biotechnologies Corp. is engaged in the development of novel biosensors.
Adaptive Biotechnologies announced the completion of Adaptive’s Series F financing round with a $195 million investment to support several strategic growth initiatives. This round was led by Matrix ...
Lion Biotechnologies has submitted an application to the FDA for approval to initiate a midstage trial of its autologous T ce -More-
Matinas BioPharma Holdings has acquired all of the outstanding stock of Aquarius BioTechnologies, an innovative bio-delivery drug discovery company with a novel and proprietary lipid-crystal nano-part...
Using proceeds from its concurrent $94mm Series E round, Adaptive Biotechnologies Corp. acquired fellow private clinical diagnostics developer Sequenta Inc. (immunosequencing).
Drugs and Medications
Abstract The absence of comprehensive federal oversight of human biotechnologies in the United States continues to stimulate academic discourse on the relative merits of European-style regulatory agen...
Reliance on intuitive and emotive responses is widespread across many areas of bioethics, and the current debate on biotechnological human enhancement is particularly interesting in this respect. A st...
Sialyltransferases are important enzymes of glycobiology and the related biotechnologies. The development of sialyltransferases calls for access to quick, inexpensive and robust analytical tools. We e...
Nursing Sciences are at a moment of paradigmatic transition. The aim of this paper is to reflect on the new epistemological paradigms of nursing science from a critical approach. In this paper, we ide...
Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeu...
Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and ...
Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...
Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides
More Information about "Nexia Biotechnologies Inc" on BioPortfolio
We have published hundreds of Nexia Biotechnologies Inc news stories on BioPortfolio along with dozens of Nexia Biotechnologies Inc Clinical Trials and PubMed Articles about Nexia Biotechnologies Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nexia Biotechnologies Inc Companies in our database. You can also find out about relevant Nexia Biotechnologies Inc Drugs and Medications on this site too.